Related Experiment Video

Updated: Jun 20, 2026

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay
06:08

Immunofluorescent Labeling in Nasal Mucosa Tissue Sections of Allergic Rhinitis Rats via Multicolor Immunoassay

Published on: September 22, 2023

Nonasthmatic nasal polyposis patients with allergy exhibit greater epithelial MMP positivity

Hyun-Woo Shin1, Doo Hee Han, Yune Sung Lim

  • 1Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|September 30, 2009
PubMed
Abstract

Insights

Allergic rhinitis (AR) significantly increases matrix metalloproteinase (MMP)-9, MMP-2, and tissue inhibitor of metalloproteinase (TIMP)-1 expression in nasal polyps. This suggests AR influences airway remodeling in nasal polyposis.

Area of Science:

  • Otorhinolaryngology
  • Immunology
  • Molecular Biology

Background:

  • Allergic rhinitis (AR) is a common condition affecting the upper airways.
  • Nasal polyposis is often associated with chronic inflammation.
  • Matrix metalloproteinases (MMPs) and their inhibitors play roles in tissue remodeling.

Purpose of the Study:

  • To investigate the impact of allergic rhinitis on the expression of MMP-9, MMP-2, and TIMP-1.
  • To compare these expressions in nasal polyp tissue and maxillary sinus mucosa.
  • To understand the role of these proteins in airway remodeling in nasal polyposis.

Main Methods:

  • A case-control study involving 20 AR patients and 20 nonallergic controls.
  • Analysis of nasal polyp (NP) and maxillary sinus mucosa (MM) samples.
  • Immunohistochemical staining and histological analysis (Trichrome, PAS, H&E) to assess protein expression and cellular infiltration.

Main Results:

  • Eosinophil infiltration was more pronounced in NP, particularly in AR patients.
  • AR patients showed significantly higher expression of MMP-9, MMP-2, and TIMP-1 in NP compared to controls.
  • No significant differences in MM protein expression were found between AR patients and controls.

Conclusions:

  • Allergic rhinitis appears to upregulate MMP-9, MMP-2, and TIMP-1 expression in nasal polyposis.
  • These findings suggest a potential mechanism for AR-associated airway remodeling.
  • Further research is warranted to elucidate the precise role of these proteins in the pathogenesis of nasal polyposis.

More Related Videos

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...